Mismatch between flap and stromal areas after laser in situ keratomileusis as source of flap striaeCHARMAN, William N.Journal of cataract and refractive surgery. 2002, Vol 28, Num 12, pp 2146-2152, issn 0886-3350, 7 p.Article

Lipids, lipophilic drugs, and oral drug delivery: Some emerging conceptsCHARMAN, William N.Journal of pharmaceutical sciences. 2000, Vol 89, Num 8, pp 967-978, issn 0022-3549Article

Intestinal lymphatic drug transport : an updatePORTER, Christopher J. H; CHARMAN, William N.Advanced drug delivery reviews. 2001, Vol 50, Num 1-2, pp 61-80, issn 0169-409XArticle

The role of retinal adaptation in night drivingPLAINIS, Sotiris; MURRAY, Ian J; CHARMAN, William N et al.Optometry and vision science. 2005, Vol 82, Num 8, pp 682-688, issn 1040-5488, 7 p.Article

Theoretical effect of changes in entrance pupil magnification on wavefront-guided laser refractive corneal surgeryCHARMAN, William N; ATCHISON, David A.Journal of refractive surgery (1995). 2005, Vol 21, Num 4, pp 386-391, issn 1081-597X, 6 p.Article

Oily formulations for administration to the gastro-intestinal tractPOUTON, Colin W; CHARMAN, William N.Advanced drug delivery reviews. 1997, Vol 25, Num 1, issn 0169-409X, 129 p.Serial Issue

Transport and absorption of drugs via the lymphatic systemPORTER, Christopher J. H; CHARMAN, William N.Advanced drug delivery reviews. 2001, Vol 50, Num 1-2, issn 0169-409X, 172 p.Serial Issue

The mucosa of the small intestine: How clinically relevant as an organ of drug metabolism?DOHERTY, Margaret M; CHARMAN, William N.Clinical pharmacokinetics. 2002, Vol 41, Num 4, pp 235-253, issn 0312-5963Article

An examination of the interplay between enterocyte-based metabolism and lymphatic drug transport in the ratTREVASKIS, Natalie L; PORTER, Christopher J. H; CHARMAN, William N et al.Drug metabolism and disposition. 2006, Vol 34, Num 5, pp 729-733, issn 0090-9556, 5 p.Article

Application of compartmental modeling to an examination of in vitro intestinal permeability data: Assessing the impact of tissue uptake, P-glycoprotein, and CYP3AJOHNSON, Brendan M; CHARMAN, William N; PORTER, Christopher J. H et al.Drug metabolism and disposition. 2003, Vol 31, Num 9, pp 1151-1160, issn 0090-9556, 10 p.Article

Does stereoselective lymphatic absorption contribute to the enantioselective pharmacokinetics of halofantrine in vivo?SHACKLEFORD, David M; PORTER, Christopher J. H; CHARMAN, William N et al.Biopharmaceutics & drug disposition. 2003, Vol 24, Num 4, pp 153-157, issn 0142-2782, 5 p.Article

Using the polymer partitioning method to probe the thermodynamic activity of poorly water-soluble drugs solubilized in model lipid digestion productsBOYD, Ben J; PORTER, Christopher J. H; CHARMAN, William N et al.Journal of pharmaceutical sciences. 2003, Vol 92, Num 6, pp 1262-1271, issn 0022-3549, 10 p.Article

Formulation of self-emulsifying drug delivery systemsPOUTON, C. W.Advanced drug delivery reviews. 1997, Vol 25, Num 1, pp 47-58, issn 0169-409XArticle

Characterisation and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situ densitometric analysisSEK, Leab; PORTER, Christopher J. H; CHARMAN, William N et al.Journal of pharmaceutical and biomedical analysis. 2001, Vol 25, Num 3-4, pp 651-661, issn 0731-7085Article

Sensitive method for the quantitative determination of proguanil and its metabolites in rat blood and plasma by liquid chromatography-mass spectrometryLEVEQUE, Nathalie L; CHARMAN, William N; CHIU, Francis C. K et al.Journal of chromatography. B. 2006, Vol 830, Num 2, pp 314-321, issn 1570-0232, 8 p.Article

The physiology of the lymphatic systemSWARTZ, Melody A.Advanced drug delivery reviews. 2001, Vol 50, Num 1-2, pp 3-20, issn 0169-409XArticle

Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated ratsCALIPH, Suzanne M; CHARMAN, William N; PORTER, Christopher J. H et al.Journal of pharmaceutical sciences. 2000, Vol 89, Num 8, pp 1073-1084, issn 0022-3549Article

The formulation of Halofantrine as either non-solubilising PEG 6000 or solubilising lipid based solid dispersions : Physical stability and absolute bioavailability assessmentKHOO, Shui-Mei; PORTER, Christopher J. H; CHARMAN, William N et al.International journal of pharmaceutics. 2000, Vol 205, Num 1-2, pp 65-78, issn 0378-5173Article

Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic productsSEK, Leab; PORTER, Christopher J. H; KAUKONEN, Ann Marie et al.Journal of pharmacy and pharmacology. 2002, Vol 54, Num 1, pp 29-41, issn 0022-3573Article

Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphaticsHUSSAIN, Nasir; JAITLEY, Vikas; FLORENCE, Alexander T et al.Advanced drug delivery reviews. 2001, Vol 50, Num 1-2, pp 107-142, issn 0169-409XArticle

Uptake of drugs into the intestinal lymphatics after oral administrationPORTER, C. J. H; CHARMAN, W. N.Advanced drug delivery reviews. 1997, Vol 25, Num 1, pp 71-89, issn 0169-409XArticle

Lipid-based vehicles for the oral delivery of poorly water soluble drugsHUMBERSTONE, A. J; CHARMAN, W. N.Advanced drug delivery reviews. 1997, Vol 25, Num 1, pp 103-128, issn 0169-409XArticle

The Mechanism of Lymphatic Access of Two Cholesteryl Ester Transfer Protein Inhibitors (CP524,5I5 and CP532,623) and Evaluation of Their Impact on Lymph Lipoprotein ProfilesTREVASKIS, Natalie L; SHANKER, Ravi M; CHARMAN, William N et al.Pharmaceutical research. 2010, Vol 27, Num 9, pp 1949-1964, issn 0724-8741, 16 p.Article

A novel cubic phase of medium chain lipid origin for the delivery of poorly water soluble drugsKOSSENA, Greg A; CHARMAN, William N; BOYD, Ben J et al.Journal of controlled release. 2004, Vol 99, Num 2, pp 217-229, issn 0168-3659, 13 p.Article

Influence of physicochemical properties on the patterns of association of a series of aliphatic esters of halofantrine with plasma lipoproteinsMCINTOSH, Michelle P; CHARMAN, William N; CAMPBELL, Michael et al.Journal of controlled release. 2004, Vol 95, Num 2, pp 275-289, issn 0168-3659, 15 p.Article